Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence

Summary

A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Tolerability, and Efficacy of OCF001 Intravaginal Gel in Women with Acute Vulvovaginal Candidiasis

Timeline

Start

2026-06-04

Primary completion

2026-12-31

Completion

2026-12-31

Drugs

Indications